Table 2.
Delafloxacin and comparator activity against S. pneumoniae serotypes
| Serotype/antibiotic | MIC50 (mg/L) | MIC90 (mg/L) | MIC range (mg/L) | Susceptible (%) |
|---|---|---|---|---|
| All S. pneumoniae serotypes (n = 142) | ||||
| Delafloxacin | 0.015 | 0.015 | 0.004–0.03 | 100 |
| Moxifloxacin | 0.25 | 0.25 | 0.06–0.25 | 100 |
| Azithromycin | 0.25 | >32 | 0.06–>32 | 76.1 |
| Penicillina | ≤0.03 | 2 | ≤0.03–4 | 71.8 |
| Clindamycin | 0.06 | >32 | ≤0.015–>32 | 85.2 |
| Ceftriaxone | 0.015 | 0.5 | ≤0.008 | 100 |
| S. pneumoniae serotype 3 (n = 27) | ||||
| Delafloxacin | 0.015 | 0.03 | 0.008–0.03 | 100 |
| Moxifloxacin | 0.25 | 0.25 | 0.12–0.25 | 100 |
| Azithromycin | 0.12 | 0.25 | 0.06–0.25 | 100 |
| Penicillina | ≤0.03 | ≤0.03 | ≤0.03–0.06 | 100 |
| Clindamycin | 0.06 | 0.06 | ≤0.015–0.12 | 100 |
| Ceftriaxone | 0.015 | 0.015 | ≤0.008–0.015 | 100 |
| S. pneumoniae serotype 19F (n = 14) | ||||
| Delafloxacin | 0.015 | 0.015 | 0.004–0.03 | 100 |
| Moxifloxacin | 0.12 | 0.25 | 0.12–0.25 | 100 |
| Azithromycin | 0.25 | >32 | 0.12–>32 | 85.7 |
| Penicillina | 0.25 | 2 | ≤0.03–2 | 14.3 |
| Clindamycin | 0.06 | 0.5 | 0.06–>32 | 85.7 |
| Ceftriaxone | 0.06 | 0.5 | 0.015–1 | 100 |
| S. pneumoniae serotype 23F (n = 10) | ||||
| Delafloxacin | 0.015 | 0.015 | 0.004–0.015 | 100 |
| Moxifloxacin | 0.12 | 0.25 | 0.06–0.25 | 100 |
| Azithromycin | 2 | >32 | 0.25–>32 | 40 |
| Penicillina | ≤0.03 | 2 | ≤0.03–2 | 50 |
| Clindamycin | 0.06 | >32 | 0.06–>32 | 80 |
| Ceftriaxone | 0.12 | 1 | 0.015–1 | 100 |
CLSI oral penicillin breakpoints.20